miR-519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Nasopharyngeal carcinoma (NPC) is a prevalent malignancy in Southeast Asia with incompletely understood regulatory mechanisms.
• MicroRNA-519 (miR-519) has demonstrated tumor-inhibitory roles in various cancers, but its function in NPC remains uninvestigated.

Purpose of the Study:

• To investigate the role and mechanism of miR-519 in the regulation of nasopharyngeal carcinoma cell proliferation.
• To identify the direct target of miR-519 involved in NPC progression.

Main Methods:

• Quantitative real-time PCR to assess miR-519 and URG4 expression levels in NPC cells and tissues.
• Cell proliferation assays (e.g., MTT) and cell cycle analysis (flow cytometry) upon miR-519 overexpression or knockdown.
• Luciferase reporter assays to confirm the direct binding of miR-519 to the 3'UTR of URG4.
• Western blotting to analyze the expression of cell cycle regulatory proteins (Cyclin D1, p-Rb, p21, p27).

Main Results:

• miR-519 was found to be significantly downregulated in NPC cells.
• Overexpression of miR-519 inhibited NPC cell proliferation and induced G0/G1 cell cycle arrest, while its knockdown promoted proliferation and cell cycle progression.
• URG4 (upregulated gene-4) was identified as a direct target of miR-519, with its expression being upregulated in NPC cells.
• miR-519 suppressed URG4 expression by binding to its 3'UTR, consequently inhibiting Cyclin D1 and p-Rb phosphorylation while increasing p21 and p27 levels, thereby blocking G1/S transition.
• A negative correlation between miR-519 and URG4 levels was observed in NPC tissues.

Conclusions:

• miR-519 functions as a tumor suppressor in nasopharyngeal carcinoma.
• The miR-519/URG4 axis plays a critical role in regulating NPC cell proliferation and cell cycle progression.
• miR-519 represents a potential therapeutic biomarker and target for nasopharyngeal carcinoma treatment.